Validation of Finasteride Tablets USP by HPLC Isocratic with UV Detector

    Debasish Mohapatra, Rahul Nayak, Debadash Panigrahi, Surya Narayan Das
    Image of study
    TLDR The method is effective and suitable for testing finasteride tablets.
    The study aimed to validate an analytical method for evaluating finasteride in bulk drug commercial products using HPLC with UV detection. The method involved eluting finasteride from a Kromasil ODS C18 column with a mobile phase of acetonitrile and ortho phosphoric acid. The analysis showed a retention time of 3.45 minutes and was completed in under 8 minutes. The method was assessed for various parameters such as specificity, precision, and stability, all of which met the acceptance criteria. The method's ruggedness was confirmed through intermediate precision tests. Statistical comparisons using t-test and F-test indicated that the method is sensitive, selective, and suitable for quality control testing, adhering to ICH guidelines.
    Discuss this study in the Community →

    Research cited in this study

    6 / 6 results

    Related Community Posts Join

    6 / 1000+ results

      community Recovery from 2nd Dutasteride shed

      in Update  16 upvotes 7 months ago
      User switched from finasteride to dutasteride due to shedding, experienced two sheds, and now uses 5mg oral minoxidil, 0.5mg dutasteride, and 3ml oral castor oil daily. Hair has recovered from the second shed, and the user plans to maintain the current treatment.
      [object Object]

      community CB-03-01: I need help

      in Treatment  7 upvotes 4 years ago
      The user stopped using finasteride and RU58841 and is considering CB-03-01 for androgenic alopecia but is concerned about the cost and effectiveness, especially at a lower dose than in clinical trials. They are also using minoxidil, micro-needling, and nizoral shampoo but are unsure about the correct application method for CB-03-01.

      community Feel like I'm a reasonably good responder

      in Is this regrowth?  274 upvotes 4 months ago
      The user "OP" reported significant hair regrowth using oral finasteride, oral and topical minoxidil, ketoconazole shampoo, and derma stamping. OP experienced initial shedding but no other side effects.

      community The New, Improved CB-03-01/Setipiprant Group Buy

       28 upvotes 8 years ago
      The group buy for CB-03-01, a topical anti-androgen for hair loss, was postponed and refunded due to issues with the product's form and solubility. The product, also known as Breezula, is an alternative to finasteride with fewer side effects, but its official release is delayed until 2021.

      community Minoxidil, RU58841, CB-03-01, WAY-316606, and derma stamping.

      in Minoxidil  5 upvotes 5 years ago
      The user is using Minoxidil, RU58841, CB-03-01, WAY-316606, Ketoconazole, MK-677, and derma stamping to treat hair loss and has noticed new hair growth, especially around the temples and hairline. They apply different treatments at various times of the day and have seen improvements in skin condition and body hair texture.

    Related Research

    1 / 1 results